Abstract:
The life expectancy of Tanzania has declined since 1990, and the health care services are facing immense challenges. The two single most important sources of burden of disease in the country are HIV/AIDS and malaria. Cardiovascular and other non-communicable diseases are also becoming increasingly important causes of disease burden. This chapter reviews the available economic evaluation literature for all types of health interventions in Tanzania. Economic evaluation is useful for setting health care priorities when decision makers are concerned about producing as much health benefits as possible within the limits of scarce health care resources.
A total of 23 studies were found reporting costs and benefits for health interventions in Tanzania. The studies included in the review can roughly be sorted into the disease groups malaria, HIV/AIDS, maternal and perinatal health, intestinal parasites and worms, tuberculosis (TB), childhood diseases and cardiovascular disorders. The economic evaluation evidence for Tanzania is generally very scarce. Evidence is relatively good for malaria interventions and interventions against intestinal worms and parasites. Within these disease groups economic evaluation can be particularly useful to inform implementation policy. For all other disease groups, evidence is either vastly insufficient or totally missing. Lack of evidence is particularly striking for treatment and care of patients with HIV/AIDS, and for non-communicable diseases. Economic evaluation can in most cases not be used efficiently and consistently to set health care priorities in Tanzania. More research is needed to improve this situation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AIDS:
-
acquired immunodeficiency syndrome
- AL:
-
artemether-lumefantrine
- AMMP:
-
adult mortality and morbidity project
- AQ:
-
amodiaquine
- ARV:
-
antiretroviral
- AS:
-
artesunate
- ASA:
-
aspirin
- BET:
-
betablocker
- BOD:
-
burden of disease
- CAB:
-
calcium channel blocker
- CER:
-
cost-effectiveness ratio
- CMH:
-
commission on macroeconomics and health
- CV:
-
cardiovascular
- DALY:
-
disability adjusted life year
- DEC:
-
diethylcarbamazine
- DIU:
-
diuretic
- DOT:
-
directly observed treatment
- EbyC:
-
evacuation by curettage
- EPI:
-
expanded programme for immunization
- GDP:
-
gross domestic product
- HIV:
-
human immunodeficiency virus
- ICER:
- IMCI:
-
integrated management of childhood illness
- ITN:
-
insecticide treated bednets
- LY:
-
life year
- MVA:
-
manual vacuum aspiration
- NBS:
-
National Bureau of Statistics
- ORS:
-
oral rehydration solution
- PMTCT:
-
prevention of mother to child transmission
- POC:
-
point of care testing
- RPR:
-
rapid plasma reagin testing
- SP:
-
sulfadoxine-pyrimethamine
- SSA:
-
Sub Saharan Africa
- STA:
-
statin
- STD:
-
sexually transmitted diseases
- TB:
-
tuberculosis
- TNVS:
-
Tanzania National Voucher Scheme
- USD:
-
United States dollars
- VCT:
-
voluntary counseling and testing
- WHO:
-
World Health Organization
References
Alonzo Gonzalez M, Menendez C, Font F, Kahigwa E, Kimario J, Mshinda H, Tanner M, Bosch-Capblanch X, Alonso PL. (2000). Bull World Health Organ. 78: 97–107.
AMMP. (2004). AMMP Final Report–The Policy Implications of Tanzanias Mortality Burden: A 10 year Community-Based Perspective. Adult Mortality and Morbidity Project–Ministry of Health, Dar es Salaam.
Ansell J, Guyatt HL. (2002). Ann Trop Med Parasitol. 96: 145–153.
Borgdorff MW, Floyd K, Broekmans JF. (2002). Bull World Health Organ. 80: 217–227.
Brock D, Wikler D. (2006). In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P (eds.) Disease Control Priorities in Developing Countries. Oxford University Press and the World Bank, New York.
Bryce J, Gouws E, Adam T, Black R, Schellenberg J, Manzi F, Victora C, Habicht J. (2005). Health Policy Plan. 20(Suppl 1): i69–i76.
Bureau of Economic Analysis (web-page), http://www.bea.gov/national/nipaweb (accessed 2008).
Canning D. (2006). J Econ Perspect. 20: 121–142.
Commission on Macroeconomics and Health & WHO. (2001). Macroeconomics and Health: Investing in Health for Economic Development. WHO, Geneva.
Creese A, Floyd K, Alban A, Guinness L. (2002). Lancet. 359: 1635–1643.
de Jonghe E, Murray CJ, Chum HJ, Nyangulu DS, Salomao A, Styblo K. (1994). Int J Health Plann Manage. 9: 151–181.
Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Buttner M, Adjei O, Buttner D, Hoerauf A. (2007). Trop Med Int Health. 12: 1433–1441.
Gilson L, Mkanje R, Grosskurth H, Mosha F, Picard J, Gavyole A, Todd J, Mayaud P, Swai R, Fransen L, Mabey D, Mills A, Hayes R. (1997). Lancet. 350: 1805–1809.
Globalis. (2008) (web-page), http://Globalis.gvu.unu.edu (accessed 2008).
Guyatt H, Evans D, Lengeler C, Tanner M. (1994). Health Policy Plan. 9: 385–395.
Guyatt HL, Brooker S, Kihamia CM, Hall A, Bundy DA. (2001). Bull World Health Organ. 79: 695–703.
Hanson K, Kikumbih N, Armstrong Schellenberg J, Mponda H, Nathan R, Lake S, Mills A, Tanner M, Lengeler C. (2003). Bull World Health Organ. 81: 269–276.
Jacobs B, Mercer A. (1999). Health Policy Plan. 14: 354–362.
Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P. (2006). Disease Control Priorities in Developing Countries. The World Bank and Oxford University Press, New York.
Kumaranayake L, Watts C. (1998). Lancet. 351: 989–990.
Lopez AD, Ahmad OB, Guillot M, Inoue M, Ferguson BD, Salomon JA. (2001). Life Tables for 191 Countries for 2000: Data, Methods, Results (GPE Discussion Paper No. 40), Evidence and Information for Policy (EIP). World Health Organisation, Geneva.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. (2006). Lancet. 367: 1747–1757.
Lubell Y, Reyburn H, Mbakilwa H, Mwangi R, Chonya S, Whitty CJ, Mills A. (2008). Br Med J. 336: 202–205.
Magotti RF, Munjinja PG, Lema RS, Ngwalle EK (1995). East Afr Med J. 72: 248–251.
Marseille E, Hofmann PB, Kahn JG. (2002). Lancet. 359: 1851–1856.
Mayaud P, Ka-Gina G, Grosskurth H. (1998). Int J STD AIDS. 9(Suppl 1): 11–14.
Michael E, Meyrowitsch DW, Simonsen PE. (1996). Trop Med Int Health. 1: 414–426.
Moses S, Plummer FA, Nagelkerke NJ. (2000). Lancet. 356: 1602–1603.
Mulligan JA, Yukich J, Hanson K. (2008). Malar J. 7: 32.
Murray C, Lopez A. (1996). The Global Burden of Disease. A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. The Harvard School of Public Health.
Murray CJ. (1991). Bull Int Union Tuberc Lung Dis. 66: 149–156.
Murray CJ, DeJonghe E, Chum HJ, Nyangulu DS, Salomao A, Styblo K. (1991). Lancet. 338: 1305–1308.
Robberstad B, Hemed Y, Norheim OF. (2007). Cost Eff Resour Alloc. 5: 3.
Robberstad B, Strand T, Black RE, Sommerfelt H. (2004). Bull World Health Organ. 82: 523–531.
Setel P, Hemed Y, Whiting D, Masanja H, Lewanga M, Mswia R, Kitange H. (2001). Insights Health, (2001).
Sherr L, Lopman B, Kakowa M, Dube S, Chawira G, Nyamukapa C, Oberzaucher N, Cremin I, Gregson S. (2007). AIDS. 21: 851–860.
Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, Kamenga C, Grinstead O, Coates T. (2000). Lancet. 356: 113–121.
Sweat MD, O’Reilly KR, Schmid GP, Denison J, de Zoysa I. (2004). AIDS. 18: 1661–1671.
Tanzania. (2002). Census (web-page), http://www.tanzania.go.tz/census/census/index.html (accessed 2008).
Tanzania. (2007). Tanzania in Figures 2006, National Bureau of Statistics, Ministry of Planning, Economy and Empowerment. Dar es Salaam.
Taylor MJ, Makunde WH, McGarry HF, Turner JD, Mand S, and Hoerauf A. (2005). Lancet. 365: 2116–2121.
Tediosi F, Hutton G, Maire N, Smith T A, Ross A, Tanner M. (2006). Am J Trop Med Hyg. 75: 131–143.
Terris-Prestholt F, Watson-Jones D, Mugeye K, Kumaranayake L, Ndeki L, Weiss H, Changalucha J, Todd J, Lisekie F, Gumodoka B, Mabey D, Hayes R. (2003). Sex Transm Infect. 79: 375–381.
Thielman NM, Chu HY, Ostermann J, Itemba DK, Mgonja A, Mtweve S, Bartlett JA, Shao JF, Crump JA. (2006). Am J Public Health. 96: 114–119.
Vickerman P, Peeling RW, Terris-Prestholt F, Changalucha J, Mabey D, Watson-Jones D, Watts C. (2006). Sex Transm Infect. 82(Suppl 5): v38–v43.
Wagstaff A, Claeson M. (2004). The Millennium Development Goals for Health. Rising to the Challenges. The World Bank, Washington DC.
Wandwalo E, Robberstad B, Morkve O. (2005). Cost Eff Resour Alloc. 3: 6.
WHO. (1999). Report of the Meeting of Experts in Blood Transfusion Services. World Health Organization. Department of Blood Safety and Clinical Technology, Geneva.
WHO. (2004). Devorming for Health and Development. Report of the Third Global Meeting of the Partners for Parasite Control. World Health Organization, Geneva.
WHO. (2006). World Health Report 2006. World Health Organisation, Geneva.
WHO (web-page), http://www3.who.int/choice/(accessed 2008).
Wiseman V, Kim M, Mutabingwa TK, Whitty CJ. (2006). PLoS Med. 3: e373.
WorldBank. (1993). World Development Report 1993: Investing in Health. Oxford University Press, New York.
Acknowledgments
We thank Ole Frithjof Norheim and Kjell Arne Johansson for peer review of the manuscript and Julia Norman for proofreading.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Robberstad, B., Hemed, Y. (2010). Economic Evaluation of Health Interventions: Tanzania Perspectives. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_33
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_33
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine